Latest News - LabCorp
Top Corporates Hub
LabCorp
Labcorp (LH) Net Margin Surges to 6.2%, Reinforcing Bullish Earnings Turnaround Narrative
30.10.2025 04:33
Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a longer-term earnings decline of 30.6% per year. Shares sit at $248.14, notably below the estimated fair value of $557.86. The current price-to-earnings ratio of 24.1x is higher than peer and industry averages. Investors are eyeing a potential turnaround as earnings are forecast to grow 14% per...
Fertility Test Market Report 2025-2033, with Profiles of Quest Diagnostics, Mayo Clinic Laboratories, Ovation Fertility, Illume Fertility, Proov, BioMerieux, Labcorp, CCRM Fertility, and Maven Clinic
21.10.2025 14:00
Opportunities in the global fertility test market include rising demand due to lifestyle changes, delayed pregnancies, and increasing infertility rates. Growing awareness and acceptance of fertility testing, alongside the prevalence of reproductive disorders, also drive market expansion across diverse demographics globally. Fertility Test Market Fertility Test Market Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Fertility Test Market Size, Share & Trends Analysis Report by Test Type (Ovulation
Labcorp Holdings Inc. (LH) Hits Fresh High: Is There Still Room to Run?
21.10.2025 13:15
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Labcorp (LH): Assessing Valuation After Monthlong Share Price Gains and Analyst Target Approaches
20.10.2025 00:14
Labcorp Holdings (LH) shares inched up about 1% today, adding to their steady gains over the past month. With recent momentum continuing, investors are considering what factors could drive further moves in the healthcare giant’s stock. See our latest analysis for Labcorp Holdings. Labcorp Holdings has delivered a robust run this year, with the share price rallying more than 25% year to date and momentum accelerating over the past quarter. Investors have seen an impressive 34% total...
Labcorp (LH) Upgraded to Buy: What Does It Mean for the Stock?
09.10.2025 16:00
Labcorp (LH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
09.10.2025 14:54
Tempus AI sharpens its edge in precision medicine with key acquisitions, strong R&D launches, and improving financials amid rising competition.
Why Labcorp Holdings (LH) is a Top Growth Stock for the Long-Term
09.10.2025 13:45
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Holdings’ Q3 2025 Earnings: What to Expect
08.10.2025 10:15
Labcorp Holdings is set to release its third-quarter earnings this month, and analysts anticipate solid double-digit growth in its bottom line, reflecting continued strength across its diagnostics and biopharma services.
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
24.09.2025 13:15
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
LH Stock Rises on Acquisition of BioReference Health's Select Assets
17.09.2025 13:52
Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.
Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
09.09.2025 10:26
Get insights on Labcorpâs growth outlook, acquisition strategy
Is it the Right Time to Hold Labcorp Stock in Your Portfolio?
26.08.2025 12:25
LH witnesses growth in specialty testing and strategic acquisitions, but macro and currency headwinds remain a concern.
Drug Discovery Services Company Evaluation Report 2025 | LabCorp, Evotec, and Selvita Lead with Comprehensive Research and Laboratory Services
14.08.2025 11:50
The Drug Discovery Services Companies Quadrant provides an in-depth analysis of the drug discovery services market, highlighting key players, technological advancements, and trends. Conducted by MarketsandMarkets 360 Quadrants, over 150 companies were evaluated, recognizing the Top 25 as leaders in the industry. Contract Research Organizations (CROs) offer extensive services such as hit identification and hit-to-lead optimization. Market growth is fueled by increased R&D investments, a growing d
Fortrea Holdings: What Is There To Like About This Situation
08.08.2025 06:15
Curreen Capital breaks down Fortreaâs struggles and turnaround potential. Learn why this CRO stock might rebound and what it means for long-term investors.
Hero Gum Debuts at New York Mets Game, Providing Fans Opportunity to Sign Up for Gift of Life Marrow Registry
04.08.2025 14:00
New initiative makes joining the stem cell registry as easy as chewing gum Gift of Life Debuts Hero Gum at NY Mets Game Gift of Life Marrow Registry was honored as the Nonprofit of the Game at the NY Mets game on August 1, 2025 at Citi Field as part of its Hero Gum debut. (Photo l-r: adam&eveDDB Executive Director Alan Perlmanadam&eveDDB Executive Creative Director Jason Ashlock, Gift of Life COO Marti Freund and Gift of Life Founder & CEO Jay Feinberg) NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
30.07.2025 11:12
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finder, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed to simplify lab test selection, Test Finder enables healthcare providers to ask questions or describe conditions in plain language and receive curated test recommendations—enhancing the user experience and freeing up more time for patient care.
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific
30.07.2025 09:26
The global Formulation Development Outsourcing Market is projected to grow from US$ 33.6 billion in 2024 to US$ 64.74 billion by 2033, at a CAGR of 7.56%. Key growth drivers include rising R&D costs, demand for specialized knowledge, complex regulations, and an expanding pharmaceutical industry. As pharmaceutical and biotech companies increasingly rely on contract development and manufacturing organizations (CDMOs) for integrated, end-to-end services, markets in North America, Europe, and the ra